Find Federal Grants
SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY
Advanced Research Projects Agency Energy · DE-FOA-0003467
Bureau of Democracy Human Rights and Labor · DFOP0016957
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
National Institutes of Health · PAR-25-055
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-020
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-CA-25-010
U.S. Mission to Argentina · PAS-AR200-FY25-01
Administration for Community Living · HHS-2025-ACL-NIDILRR-AREM-0102
Administration for Community Living · HHS-2025-ACL-NIDILRR-ARHF-0101
Advanced Rehabilitation Research Training (ARRT) Program - Community Living and Participation
Administration for Community Living · HHS-2025-ACL-NIDILRR-ARCP-0100
Advanced Rehabilitation Research Training (ARRT) Program - Disability Policy Research
Administration for Community Living · HHS-2025-ACL-NIDILRR-ARPO-0103
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-CA-25-009
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
National Institutes of Health · PA-25-080
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-25-013
DOC NOAA - ERA Production · NOAA-NOS-OCM-2025-28205
Defense Threat Reduction Agency · HDTRA1-25-S-0001
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health · PAR-24-294
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · PAR-24-293
Agency for International Development · 7200AA25RFI00TBD
Environmental Protection Agency · EPA-OA-OSDBU-25-01
FY25 Long Range Broad Agency Announcement (BAA) for Navy and Marine Corps Science and Technology
Office of Naval Research · N0001425SB001